Comparison if the addition of multilevel vertebral augmentation to conventional therapy will improve the outcome of patients with multiple myeloma by Ziad A Audat et al.
RESEARCH Open Access
Comparison if the addition of multilevel
vertebral augmentation to conventional
therapy will improve the outcome of
patients with multiple myeloma
Ziad A Audat1*, Mahmoud H. Hajyousef2, Mohammad D. Fawareh3, Khaldoon M. Alawneh2, Mohannad A. Odat4,
Mohammad M. Barbarawi2, Ali A. Alomari2, Rami A. Jahmani2, Mohammad A. Khatatbeh2
and Mohammed A. Assmairan2
Abstract
Background: This was a prospective study to evaluate the effect of multilevel vertebral augmentation in addition
to conventional therapy in multiple myeloma patients.
Methods: We treated 27 patients, whom were recently diagnosed to have multiple myeloma by two ways of
treatment. Thirteen patients (group I) were treated with conventional therapy and 14 patients (group II) with adding
vertebroplasty and kyphoplasty. Patients were evaluated pre-treatment and at half, one, two and 3-years post-treatment
by using Oswestry Disability Index (ODI), the Stanford Score (SS) and the Spinal Instability Neoplastic Score (SINS).
Results: Mean values of ODI, SS and SINS were 31.9 (63.8%), 4.3 and 13.8 for group I and 33.2 (66.4%), 4.6 and 12.8 for
group II before starting treatment. Group II showed improvement better than group I at all follow-up intervals with
best results at first 6 months. P-values at the end of the study were ODI = 0.047, SS = 0.180 and SINS = 0.002. Mortality
rates were equal of both groups (four patients of each group).
Conclusion: Adding vertebral augmentation to conventional therapy improves multiple myeloma patients’ quality of
life, but didn’t affect the mortality rate.
Keywords: Multiple myeloma, Vertebral augmentation, Vertebroplasty, Kyphoplasty, Chemotherapy, Radiotherapy,
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Background
Multiple myeloma is accumulation of malignant plasma
cell in the bone marrow leading to impaired blood cell for-
mation and multiple lytic lesions in the skeleton. The inci-
dence of bone involvement is about 70–100% while
vertebral column is about 60% [1–3]. Bone becomes week
and easy to fracture, which may cause pain in the bone
and inability to use the limb. In the spine, fractured verte-
bra causes pain, kyphotic or kyphoscoliotic deformity,
compression of the spinal cord or cauda equina in addition
to the general symptoms of multiple myeloma [1, 3].
General treatment of the disease includes radiotherapy,
chemotherapy and bisphosphonate to decrease bone re-
sorption in addition to analgesia, bed rest and bracing to
treat pathological fractures [1]. Minimally-invasive verteb-
roplasty and balloon kyphoplasty are used as local treat-
ment of the vertebral lesions to decrease pain and prevent
or treat deformities [3–5]. Vertebroplasty is insertion of
bone cement (polymethylmetacrylate) inside the vertebral
body using pedicle cannula unilaterally or bilaterally while
balloon kyphoplasty is insertion of balloon tamps
through pedicle cannulae to reduce the height of the
vertebra, realign the sagittal plane and create a cavity
for bone cement [6–8]. Many studies were concen-
trating on multilevel vertebroplasty and kyphoplasty
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to treat multiple myeloma, but not more than 6 and
8 levels [9, 10].
At our hospital, we used vertebral augmentation in the
management of multiple myeloma in a different way.
We perform multilevel vertebral augmentation for all
vulnerable vertebrae; thoracic, lumbar and sometimes
the first sacral vertebra. Our practice is to not wait until
the vertebra collapsed as a cause of the tumor, which
may lead to neurological sequelae. As such, the following
prospective study evaluated the outcomes of our mul-
tiple myeloma patients who underwent multilevel verte-
bral augmentation in addition to conventional therapy.
Methods
This is a prospective study of effectiveness of the addition
of vertebral augmentation to conventional chemotherapy
and radiotherapy in treating multiple myeloma patients.
Our main aims were to prevent spinal column collapse,
back deformity, neurological deficits, minimize pain and
decrease general morbidities.
We treated 27 patients diagnosed with multiple myeloma
at our institution that were newly diagnosed with more
than 3 years follow-up. All patients had back pain without
neurological deficits. All patients’ demographic data were
extracted from the medical charts, consisting of age, gen-
der, presenting symptoms, and follow-up period. Imaging
studies included plain x-ray and magnetic resonance image
(MRI) at the time of diagnosis (Figs. 1, 2, 3 and 4). The pa-
tients had histological diagnosis with bone marrow biopsy.
The involved vertebra included lesions in the thoracic,
lumbar, sacral vertebrae and cervical in one patent (C6 and
C7). Mild kyphosis was seen in half of the patients. Con-
sent form was signed by patients and Institutional Review
Board (IRB) approval was obtained.
All patients received conventional chemotherapy and
radiotherapy according to standard protocols of the
hematology oncology. Patients were then were randomly
categorized into two groups:
Group I: 13 patients were treated by conventional
treatment (i.e. chemotherapy and radiotherapy)
(Table 1).
Group II:14 patients; 206 vertebrae, number of
vertebrae ranged between 10 and 16 (mean: 14.7);
were treated by vertebral augmentation in addition
to conventional therapy (five patients with
chemotherapy and radiotherapy and nine patients
with chemotherapy) (Table 1). One patient
needed radiotherapy post augmentation.
Vertebral bodies were augmented from the third thoracic
(T3) to first sacral vertebrae (S1), all vertebrae were aug-
mented if they were fractured or vulnerable to fracture
whatever the size of the lesion. Vertebral augmentation
was done under general anesthesia in the operation room
under fluoroscope control. All levels for single patient were
done at the same session. Balloon kyphoplasty and cement
injection was used to restore the height of collapsed verte-
bra. Two balloons were used for each level. Transpedicular
Fig. 1 Anteroposterior view of thoracic and lumbar spine
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technique was used for vertebrae below T8 and extrapedi-
cular for T8 and above. Vertebroplasty was used for non-
collapsed vertebrae by inserting working cannula and injec-
tion of bone cement. We used a transpedicular technique
for vertebrae below T8 and extrapedicular for T8 and
above, unilateral working cannula for T9 and above and bi-
lateral for T10 and below (Figs. 5 and 6). Patients were ob-
served at surgical flour for one postoperative day then
transferred to the hematology ward or discharged, then
followed-up at the outpatient clinic.
Fig. 2 Lateral view of thoracic spine shows vertebrae compressed
fractures and some lytic lesions
Fig. 3 Lateral view of lumbar spine shows compressed fractures and
lytic lesions
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Patients who had spinal canal extension or spinal cord
compromise, cauda equine compression, late-stage disease
and patients who are previously underwent spinal surgery
were excluded. International scoring and questionnaire sys-
tems consisting of the Oswestry Disability Index (ODI), the
Stanford Score (SS) and the Spinal Instability Neoplastic
Score (SINS) were used to evaluate the clinical and radio-
logical results. The patients were evaluated clinically and
radiographically on discharge-day, 6, 12, 24 and 36 months.
Statistically, we used SPSS version 20 (Chicago, IL, USA)
to evaluate the results. Levene’s test for equality of variances
was used to evaluate patients at each follow-up interval.
This test gives mean values, standard deviation and p-value.
Test of between-subjects effect, transformed variables:
Average using ANOVA Method to evaluate the end results.
Results
We treated 27 patients, whom were recently diagnosed with
multiple myeloma. There were 13 patients in group I (con-
ventional treatment) and 14 patients in group II (n = 206
vertebrae, vertebral augmentation group). Mean age for
group I was 58.2 years, mean follow-up was 36 months and
Fig. 4 Sagittal views of thoracic and lumbar spine showed multiple lesions of the spine and fracture of many vertebrae
Table 1 Demographic and clinical characteristics of patients according to method of treatment
Group 1 Group 2
Number of patients 13 14
Age (years) 39–78 (Mean: 58.15, SD: 12.3) 34–74 (Mean: 58.86, SD: 11.99)
Sex (Male : Female) 9:4 6:8
Back Pain All patients All patients
Neurological Deficit None None
Treatment Chemo and Radiotherapy = 7
Chemotherapy = 6
Vertebroplasty and Kyphoplasty
Two hundred six vertebrae (one patient 10 v, one patient 12 v,
three patients 14 v, two patients 15, and seven patients 16 vertebrae)
in addition to Chemotherapy or Chemo and Radiotherapy
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male to female ratio was 9:4. For group II, the mean age was
58.9 years, the mean follow-up was 36 months and male to
female ratio was 6:8. There was no significant statistical dif-
ference in the age between two groups as shown in Table 1.
Four patients (30.8%) of group I died between 7 and 11
months after diagnosis: three patients due to advanced dis-
ease and one by acute pneumonia. Four patients (28.6%) of
group II died: one died at day of surgery by acute lung em-
bolism and three died 18–24 months after surgery due to
advanced disease and severe pneumonia (Table 2).
Fig. 5 Anteroposterior view of thoracic and lumbar spine with multilevel
vertebrae filled with bone cement and lateral small vascular leak
Fig. 6 Lateral view of whole spine showed multilevel vertebrae was
filled with bone cement and intraspinal cement leak
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There were few intraoperative complications in group
II. Cement leak inside the spinal canal with no signifi-
cant neurological compromise or deficits occurred in
one patient and intravascular leak in a small vessel was
seen in two patients (Figs. 5 and 6). Bone cement didn’t
affect chemotherapy or radiotherapy.
Oswestry Disability Index, Stanford score and the
Spinal Instability Neoplastic Score values were nearly
equal in both groups before treatment. ODI of group I
was 31.9 (63.8%) with SD = 8.34 and of group II was 33.2
(66.4%) with SD = 5.98 (p = 0.418). SS of group I was 4.3
(SD = 2.6) and of group II was 4.6 (SD = 2.9) (p = 0.309).
SINS of group I was 13.8 (SD = 2.9) and of group II was
12.8 (SD = 2.9) (p = 0.482).
At 6 months-follow up, group II value improved, ODI
mean values were 32.5 (64.9% and SD = 10.92) and 23.14
(46.28% and SD = 8.49) for group I and II, respectively
(p = 0.316). The SS value was 5.26 (SD 2.96) for group I
and 7.18 (SD 1.39) for group II (p = 0.05). SINS was
12.85 (SD 2.79) for group I and 7.15 SD 3.24 for group
II (p = 0.449).
At 1 year follow-up, group I score values showed more
improvement. ODI value for group I was 28.4 (56.8%)
with SD = 8.79 and for group II was 21.4 (42.8%) with
SD = 9.24 (p = 0.874). The SS value for group I was 5.28
with SD 2.88 and for group II was 7.52 with SD 1.48
(p = 0.012). SINS value for group I was 12.85 with SD 2.88
and for group II was 7.23 with SD 3.37 (p = 0.526).
At 2 years follow-up, ODI for group I was 28.42
(56.85%) with SD 8.79 and for group II was 21.43 (42.65%)
with SD 9.24 (p = 0.874). The SS for group I was 5.40
with SD 2.83 and for group II was 7.68 with SD 1.56
(p = 0.047). SINS value for group I was 12.75 with SD 2.67
and for group II was 7.31 with SD 3.43 (p = 0.278).
At 3 years follow-up, ODI for group I was 29.17
(58.34%) with SD = 9.37 and for group II was 21.43
(42.86%) with SD 9.931 (p = 0.840). The SS mean value
for group I was 5.27 with SD 2.94 and for group II was
7.83 with SD 1.64 (p = 0.040). SINS mean value for
group I was 12.58 with SD 2.75 and for group II was
7.36 with SD = 3.72 a (p = 0.121).
At the end of the study (3 years), we used test of
between-subjects effect, transformed variables: average
using ANOVA method to compare the end results of
each group. ODI and SINS showed significant difference
between two groups (p = 0.047 and p = 0.002) with less
significant difference by using SS (p = 0.180). All group
II were freely mobile except one who used a cane when
walk. All patients were back pain free except three, who
had number of exacerbations of pain that may be attrib-
uted to disc disease or fracture of vertebral end plate
over bone cement. All patients had preserved vertebral
height and sagittal balance except for one who had his-
tory of inter-scapular pain 4 years after surgery and x-
rays showed mild loss of height of T4 around the bone
cement which was insignificant as compared to three pa-
tients of group I who became bedridden due to vertebral
fractures with involvement of the spinal canal.
Table 2 Morbidity and mortality of each group
Group 1 Group 2
Morbidity Threepatients bed ridden due to multiple spinal
fracture and paraparesis.
Four patients can walk with aid
All still mobile without aid except one who
needs stalk aid.
Mortality Five patients: four deaths due to advancement of
the disease and one due to sepsis after 7–11
months of treatment (38.5%)
Four patients:
one at the same day of surgery due to PE,
two after 1.5 year of treatment due to advancement
of the disease and one after 1.5 years due to
pneumonia. (27.3%)
Back Pain Improvement Six patients improved partially All patients improved after Vertebroplasty with three
of them had episodes of pain.
Vertebroplasty Intraoperative Complications —— One had small leak toward the spinal canal without
neurological disorders.
One had intravascular leak.
Fig. 7 Shows Oswestry Disability Index; pre-treatment and at inter-
vals of follow up
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Discussion
This is was a prospective study to compare two groups of
multiple myeloma patients who were treated at our insti-
tute. Group I was treated with conventional therapy and
group II with multilevel vertebral augmentation in
addition to conventional therapy. We couldn’t find any
similar studies in the literature doing the same compari-
son. Most of previous studies involving multiple myeloma
discussed mixed population of malignancy and were not
focused such a disease. Few studies that focused on mul-
tiple myeloma treated only the fractured vertebra and
showed similar results of our study [9, 11–17]. Our results
showed that the addition of vertebral augmentation had
better improvement in the outcome, both subjective and
objective. The best rates of scores improvement were seen
during the first 6 months. After that, improvement rate
decreased with time, whereby group II showed better re-
sults as demonstrated in Figs. 7, 8 and 9.
The p-values (Levene’s test) of scores at each interval
of follow-up is shown in Table 3. P-value of ODI was
0.316 at 6 moths and increase to 0.87 at all interval-
follow up, which was considered insignificant. P-values
of SS were ≤0.05 at all follow up periods, which were
considered significant. P-value of SINS was 0.45 and de-
creased after 2 years to reach 0.12, which is more signifi-
cant than ODI. At the end of study, p-value (by using
ANOVA test) of ODI, SS scores, and SINS were 0.047,
0.180 and 0.002, respectively, which were statistically sig-
nificant. This means that back pain, mobility, kyphotic
deformity due to vertebral collapse and sagittal balance
were improved. Most patients of group II became ambu-
lating and totally pain free. As compared to none of
group I were pain free and half of them were ambulating
with aid.
In the literature review addressing previous studies
discussing multilevel vertebral augmentation, we found
that most of them were dealing with less than eight
levels and were performed in more than one surgical
session [9, 18]. Two case reports were found with multi-
level vertebral augmentation. The first one was used to
treat newly adjacent level fractures in a patient who was
treated for osteoporotic fracture [19]. The second case
was treated for multiple osteoporotic fractures that oc-
curred at different times after vertebroplasty in a patient
with chronic liver disease [20].
In our study, all the patients had the same disease,
were treated by the same hematologist, all procedures
were done by the same spine surgeon and evaluated by
independent physicians. In group II, 14 patients (206
vertebrae), who underwent vertebral augmentation, the
procedures were done at same session for all involved
vertebra for single patient. This decreased the need and
risk of repetitive anesthesia, although increased the op-
erative time and radiological exposure. We did several
measures to decrease surgical time and radiological
Fig. 8 Shows the Stanford Score; pre-treatment and at intervals of
follow up
Fig. 9 Shows the Spinal Instability Neoplastic Score; pre-treatment and at intervals of follow up
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exposure, inserting a working cannula directly (eliminat-
ing introducing cannula and K wire need), inserting
multiple cannulas at the same time and using unilateral
cannula at T9 and above. In addition, there was no sig-
nificant statistical difference of mortality rate between
the two groups.
Conclusion
Multilevel vertebral augmentation in addition to conven-
tional therapy showed superior results as compared with
conventional therapy alone. It relieves pain, preserves
vertebral height, sagittal balance and improves mobility
of the patients. There was no significant difference of
mortality rates between the two groups, but there was
significant improvement of morbidity rates. The limita-
tion of this study was the small sample size and variable
follow-up periods. Larger, prospective studies are needed
to further assess the outcome of such treatment modal-
ities in multiple myeloma patients.
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